Learning The New Trend In Therapeutics

Learning The New Trend In Therapeutics

therapeuticsIn 2006 US pharmaceutical preparation manufacturing gross output peaked at $133 billion. Since 2006 every year US output showed decreasing trend with total output in 2011 was $122 billion.

 

 

 

 

Reasons for this downward trend

• New drug development are lacking because it is too costly to develop a new drug. Today’s cost is right around $1.2 billion to develop a new drug and takes about 10 to 12 years to market.
• Molecular target based single chemical is problematic in side-effects often cause them (the manufacturers) to withdraw from the market once marketed.
• Many previously patented brands are becoming generic.

Health care cost on the rise

Theoretically, the US pharmaceutical preparation manufacturing output drop should equate to total health care costs decrease also. The answer is no. “The health care cost is rising very year in the US. The cost escalation is caused by higher price of medical services paying defensive medicine (prescription drugs) using a new technique and treatment without considering effectiveness a lack of transparency of information on prices and quality, etc.” Most importantly not enough emphasis on prevention of diseases. More precisely adjusting the percentage of emphasis of defensive medicine versus non-defensive (add more weight to prevention) medicine is the key to drive down the medical cost. Today more than one sixth of the US economy is devoted to health care spending and the trend of rising every year to a tune of $2.7 trillion spent in 2013.

What is the answer to this medical cost problem

Innovations in medication therapy management is the key and this include patient education in exercise diet and lifestyle management methodology improvements, adopting prescription drugs with prevention and overall “tuneup” of the disease is the key. Herbal-based Eastern philosophy combined with Western prescription drugs is going to vastly change the therapeutic landscape in the future. Case in point, since 2009 US FDA has gradually eased the allowance of herbal medicine to be researched and positioned for FDA approval. Today we have more than 450 prescription drug candidates based on herbs are in the files of FDA.

Brought to You By:
Charles H. Liu
DDP Medical Writer on Staff

Charles H. Liu, R. Ph, MBA

Facebook Twitter LinkedIn 

No comments

You must be logged in to post a comment.

Global Translator

Featured Recent Comments